Fluticason Cipla

Medicinal product

(Invented) name

Fluticason Cipla

Active substance (s)

Flutikazonas

Strength

125 µg/dozėje

Pharmaceutical form

suslėgtoji įkvepiamoji suspensija

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03BA05, Fluticasone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2022-11-22

Date of renewal

Documents

1772_Fluticason Cipla_2022-11-22.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Flutikazonas	125 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
109901	96008	1096008	slėginė talpyklė	120 dozių N1		Receptinis	LT/L/22/1772/001	Netiekiama	2024-12-10	2025-06-30	No	-	-	Download
109902	96009	1096009	slėginė talpyklė	120 dozių N2		Receptinis	LT/L/22/1772/002	Netiekiama	2025-02-06	2025-03-25	No	-	-	Download

Stadijos

Data	Stadija
2022-11-30	Registruotas
2022-11-22	Registruotas